Pfizer Made ‘Groundless Threats’ to Pharmacies in Patent Dispute

  • Allergan unit wins patent clash over generic version of Lyrica
  • U.K. judge chides Pfizer over messages to doctors & drugstores

Pfizer Inc. medication.

Photographer: Daniel Acker/Bloomberg

Pfizer Inc. was accused by a U.K. judge of making “groundless threats” of legal action against British doctors and drugstores if they prescribed or sold a generic version of its best-selling Lyrica treatment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.